1-3 of 3
Dragan Jevremovic
Close
Sort by
Journal Articles

Genetic features and clinical outcomes of patients with isolated and comutated DDX41 -mutated myeloid neoplasms

Hassan B. Alkhateeb, Ahmad Nanaa, David Viswanatha, James M. Foran, Talha Badar, Lisa Sproat, Rong He, Phuong Nguyen, Dragan Jevremovic, Mohamad E. Salama, Patricia Greipp, Naseema Gangat, Ayalew Tefferi, Mark R. Litzow, Abhishek A. Mangaonkar, Mithun Vinod Shah, Mrinal Patnaik, Aref Al-Kali
Journal: Blood Advances
Blood Adv (2022) 6 (2): 528–532.
https://doi.org/10.1182/bloodadvances.2021005738
Published: 2022
Includes: Supplemental data
Journal Articles

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

Patrick W. Mellors, Moritz Binder, Rhett P. Ketterling, Patricia T. Greipp, Linda B. Baughn, Jess F. Peterson, Dragan Jevremovic, Kathryn E. Pearce, Francis K. Buadi, Martha Q. Lacy, Morie A. Gertz, Angela Dispenzieri, Suzanne R. Hayman, Prashant Kapoor, Wilson I. Gonsalves, Yi L. Hwa, Amie Fonder, Miriam Hobbs, Taxiarchis Kourelis, Rahma Warsame, John A. Lust, Nelson Leung, Ronald S. Go, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2236–2244.
https://doi.org/10.1182/bloodadvances.2019001275
Published: 2020
Includes: Supplemental data
Journal Articles

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

Clinical Trials & Observations
Mohammed A. Aljama, M. Hasib Sidiqi, Arjun Lakshman, Angela Dispenzieri, Dragan Jevremovic, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, David Dingli, Eli Muchtar, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Wilson I. Gonsalves, Rahma Warsame, Taxiarchis V. Kourelis, Yi Lisa Hwa, Prashant Kapoor, Nelson Leung, Ronald S. Go, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3149–3154.
https://doi.org/10.1182/bloodadvances.2018024794
Published: 2018